Ioglicic acid

Ioglicic acid

Clinical data
ATC code	V08AA06 (WHO)
Identifiers
IUPAC name 3-acetamido-2,4,6-triiodo-5-{[(methylcarbamoyl)methyl]carbamoyl}benzoic acid
CAS Number	49755-67-1
PubChem CID	65437
DrugBank	DB13701
ChemSpider	58900
UNII	3LGR5S8101
KEGG	D04574
ChEMBL	ChEMBL1201291
CompTox Dashboard (EPA)	DTXSID10198023
ECHA InfoCard	100.051.320
Chemical and physical data
Formula	C13H12I3N3O5
Molar mass	670.968 g·mol−1
3D model (JSmol)	Interactive image
SMILES Ic1c(c(I)c(c(I)c1NC(=O)C)C(=O)O)C(=O)NCC(=O)NC

Ioglicic acid is a pharmaceutical drug that was used as an iodinated contrast medium for X-ray imaging, in form of its salt meglumine ioglicate. Uses included imaging of the brain, the aorta and femoral arteries, and the urinary system (an examination called intravenous urography).

It is not known to be marketed anywhere in the world in 2021.